Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05992883 · ClinicalTrials.gov registry record · Phase 3

NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis

A Phase 3 study of Thumb Osteoarthritis, sponsored by Mayo Clinic.

Recruiting
Registry status
Phase 3
Development phase
240
Enrollment target
1
Study location

NCT05992883 is a Phase 3 study of Thumb Osteoarthritis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 240 participants, above the 66-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (264% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05992883, a Phase 3 study of Thumb Osteoarthritis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Phase 3
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The Researchers are trying to compare two different types of intraarticular injections (injection in the joint) for treating the symptoms of moderate to advanced basilar thumb arthritis. One injection is ketorolac (an NSAID) and the other is triamcinolone (a corticosteroid).

Conditions Studied

Interventions

  • DRUG Ketorolac
  • DRUG Triamcinolone

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-07-28
Est. Completion 2026-12-31
Phase Phase 3

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05992883

The ClinicalTrials.gov registry entry for NCT05992883 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 66-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (264% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thumb Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Ketorolac is the first listed.

NCT05992883 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05992883 about?

NCT05992883 is a clinical study titled "NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis". The Researchers are trying to compare two different types of intraarticular injections (injection in the joint) for treating the symptoms of moderate to advanced basilar thumb arthritis. One injection is ketorolac (an NSAID) and the other is triamcinolone (a corticosteroid).

What is the current status of trial NCT05992883?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2023-07-28. Estimated completion is 2026-12-31.

What conditions does trial NCT05992883 study?

This clinical trial studies the following conditions: Thumb Osteoarthritis.

What interventions are being tested in trial NCT05992883?

The interventions under investigation include: Ketorolac (DRUG), Triamcinolone (DRUG).

Who is sponsoring clinical trial NCT05992883?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05992883 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thumb Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.